Clinical trial

The Treatment of Tuberculosis in HIV-Infected Patients

NCT00001033

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Ethambutol hydrochloride Normalized identity: ethambutol hydrochlorideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Isoniazid Normalized identity: isoniazidView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pyrazinamide Normalized identity: pyrazinamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pyridoxine hydrochloride Normalized identity: pyridoxine hydrochlorideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Levofloxacin Normalized identity: levofloxacinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Rifampin Normalized identity: rifampinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Treatment of Tuberculosis in HIV-Infected Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE3

Conditions

HIV Infectionsunresolved

Tuberculosisverified · MONDO: tuberculosis

Interventions

Ethambutol hydrochlorideDRUG · verified · RxNorm: ethambutol hydrochloride

IsoniazidDRUG · verified · RxNorm: isoniazid

PyrazinamideDRUG · verified · RxNorm: pyrazinamide

Pyridoxine hydrochlorideDRUG · verified · RxNorm: pyridoxine hydrochloride

LevofloxacinDRUG · verified · RxNorm: levofloxacin

RifampinDRUG · verified · RxNorm: rifampin

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Mapped research locations

New YorkNew York, United States3 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 MiamiFlorida, United States1 CincinnatiOhio, United States1 Washington D.C.District of Columbia, United States1 BuffaloNew York, United States1 HonoluluHawaii, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00001033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.